LEO 90105
MCB 0904
Phase 2 small_molecule completed
Quick answer
LEO 90105 for Psoriasis Vulgaris is a Phase 2 program (small_molecule) at LEO Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEO Pharma A/S
- Indication
- Psoriasis Vulgaris
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed